News
Hosted on MSN31m
The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know
The company is partnering with GoodRx to offer Ozempic at a reduced cost for patients who pay out of pocket. This move should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback